Our immune system surveils and protects every organ in our bodies by repairing injuries, destroying pathogens and killing cancer cells.

The Immunology Center of Georgia (IMMCG) represents a new initiative by the Medical College of Georgia at Augusta University to leverage the ability of the immune system to combat disease. The IMMCG will accomplish this by assembling teams of biomedical researchers with strong records of scientific innovation and technological development.

The IMMCG will be co-directed by world-class immunologists Drs. Catherine ‘Lynn’ Hedrick and Klaus Ley, both of whom have made major discoveries linking immune cells to specific mechanisms of disease.

The goal of the IMMCG is to produce novel and effective treatments for conditions that heavily impact the communities of Georgia and the United States. The new center is aggressively recruiting faculty and staff to lead projects focused on cardiovascular disease, obesity and metabolic disorders, autoimmune and infectious disease, neurodegenerative disease and cancer.

More to come on this developing center. 

 

photo of Klaus Ley, M.D.

Klaus Ley, M.D.

  • Co-Director, Immunology Center of Georgia (IMMCG)
  • Georgia Research Alliance Eminent Scholar
  • Professor, Physiology
  • Medical College of Georgia, Augusta University

Ley will serve as the co-director of the Immunology Center of Georgia. Ley is currently a professor at the La Jolla Institute for Immunology and an adjunct professor of bioengineering at the University of California San Diego. The Ley laboratory utilizes single-cell technologies (scRNA-Seq with CITE-Seq) in combination with high-resolution optical imaging (TIRF, STORM and multiphoton) to profile immune cell populations during cardiovascular disease in both human samples and animal models. Ley is a fellow of the American Heart Association and he has previously served as president of the North American Vascular Biology Organization. He has also received the 2008 Bonazinga Award, the 2010 Malpighi award, the 2017 Landis award and the 2020 Pioneers in Cardiology Award. Ley currently serves on the editorial boards of Circulation Research, The Journal of Clinical Investigation and The Journal of Experimental Medicine.

envelope icon  kley@augusta.edu 

photo of Catherine C. 'Lynn' Hedrick, Ph.D.

Catherine C. 'Lynn' Hedrick, Ph.D.

  • Co-Director, Immunology Center of Georgia (IMMCG)
  • GRA Bradley Turner Eminent Scholar in Vascular & Cancer Immunology
  • Head, Cancer Immunology, Inflammation, & Tolerance (CIIT), Georgia Cancer Center
  • Professor, Medicine
  • Medical College of Georgia, Augusta University

Hedrick will serve as both the co-director of the Immunology Center of Georgia and the director of the Cancer Immunology, Inflammation and Tolerance (CIIT) Program of the Georgia Cancer Center at Augusta University. Hedrick has been a professor at La Jolla Institute for Immunology since 2009.Her research focuses on innate myeloid cell interactions in atherosclerosis and cardiovascular disease. Specifically, her laboratory employs mass cytometry and CITE-Seq to determine how myeloid cells regulate immune responses to both cancer and atherosclerosis. Her work has uncovered specific subsets of monocytes as contributors to the progression of atherosclerosis and responsiveness to anti-tumoral immunotherapy. Hedrick has received the Hoeg Award for Basic and Clinical Research in Cardiovascular Disease and a Vascular Biology Award from the American Heart Association, as well as recent recognition as a world expert in monocytes from Expertscape. Hedrick has trained multiple researchers during her career and is a recipient of the American Heart Association Mentoring Award.

envelope icon  lhedrick@augusta.edu 

Contact Us

Immunology Center of Georgia

1410 Laney Walker Blvd,
CN4315
Augusta, GA 30912